Hikma Pharmaceuticals (HIK) Ordinary GBP 0.10

Sell:1,389.00pBuy:1,390.00pPrice decreased13.50p (0.97%)

FTSE 250:Price decreased0.89%
Market closed |
Prices delayed by at least 15 minutes

Sell:1,389.00p
Buy:1,390.00p
Change:Price decreased13.50p (0.97%)
Deal now
Market closed |
Prices delayed by at least 15 minutes

Sell:1,389.00p
Buy:1,390.00p
Change:Price decreased13.50p (0.97%)
Market closed |
Prices delayed by at least 15 minutes

Deal now

Key metrics

Open1,402.50p
Previous close1,397.00p
Market cap£2.98bn
P/E ratio8.26
Volume1,016,333
Dividend yield4.46%
EMS500

Company information

Hikma Pharmaceuticals PLC is a multinational pharmaceutical company engaged in the development, manufacturing and marketing of a broad range of generic, branded and non-licensed pharmaceutical products. Its ...

  • LocationUnited Kingdom
  • SectorHealthcare
  • IndustryBiotechnology & Drugs
  • CurrencyGBP
  • Shares in issue229.84m
Dates and announcementsDirector deals

Earnings and financials

Take a closer look at this company’s financial statements and dividend information.

Dividends

  • Dividend per share£0.266
  • Ex-dividend date14 August 2025
  • Payment date18 September 2025

Costs and Charges

Find out how much you might pay in costs and charges if you choose this investment.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete and accepts no responsibility for how it may be used. TradingView Lightweight Charts™ Copyright (c) 2026 TradingView, Inc. https://www.tradingview.com/.